SE9402106L - Lipidbaserad komposition - Google Patents

Lipidbaserad komposition

Info

Publication number
SE9402106L
SE9402106L SE9402106A SE9402106A SE9402106L SE 9402106 L SE9402106 L SE 9402106L SE 9402106 A SE9402106 A SE 9402106A SE 9402106 A SE9402106 A SE 9402106A SE 9402106 L SE9402106 L SE 9402106L
Authority
SE
Sweden
Prior art keywords
phase
biologically active
pct
active material
liquid crystalline
Prior art date
Application number
SE9402106A
Other languages
Unknown language ( )
English (en)
Other versions
SE9402106D0 (sv
SE518578C2 (sv
Inventor
Helena Ljusberg-Wahren
Kaare Larsson
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9402106A priority Critical patent/SE518578C2/sv
Publication of SE9402106D0 publication Critical patent/SE9402106D0/sv
Priority to CA002192190A priority patent/CA2192190C/en
Priority to US08/750,126 priority patent/US5807573A/en
Priority to DE69521896T priority patent/DE69521896T2/de
Priority to JP50200796A priority patent/JP3825468B2/ja
Priority to AU27563/95A priority patent/AU2756395A/en
Priority to EP95922814A priority patent/EP0767656B1/en
Priority to AT95922814T priority patent/ATE203399T1/de
Priority to PCT/SE1995/000593 priority patent/WO1995034287A1/en
Publication of SE9402106L publication Critical patent/SE9402106L/sv
Priority to FI964959A priority patent/FI964959A0/sv
Priority to NO965380A priority patent/NO965380L/no
Publication of SE518578C2 publication Critical patent/SE518578C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9402106A 1994-06-15 1994-06-15 Lipidbaserad komposition SE518578C2 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition
PCT/SE1995/000593 WO1995034287A1 (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
JP50200796A JP3825468B2 (ja) 1994-06-15 1995-05-24 ジアシルグリセロール、リン脂質、極性液体および生物活性物質を含有する脂質をベースとした組成物
US08/750,126 US5807573A (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
DE69521896T DE69521896T2 (de) 1994-06-15 1995-05-24 Präparat auf lipidbasis, das diacylglyzerin, ein phospholipid, eine polare flüssigkeit und biologisch aktives material enthält
CA002192190A CA2192190C (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
AU27563/95A AU2756395A (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
EP95922814A EP0767656B1 (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
AT95922814T ATE203399T1 (de) 1994-06-15 1995-05-24 Präparat auf lipidbasis, das diacylglyzerin, ein phospholipid, eine polare flüssigkeit und biologisch aktives material enthält
FI964959A FI964959A0 (sv) 1994-06-15 1996-12-11 Lipidbaserad sammansättning innehållande diacylglycerol, fosfolipid, plas vätska och biologiskt aktivt material
NO965380A NO965380L (no) 1994-06-15 1996-12-13 Lipidbasert blanding inneholdende diacylglycerol, fosfolipid, polar væske og biologisk aktivt materiale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition

Publications (3)

Publication Number Publication Date
SE9402106D0 SE9402106D0 (sv) 1994-06-15
SE9402106L true SE9402106L (sv) 1995-12-16
SE518578C2 SE518578C2 (sv) 2002-10-29

Family

ID=20394403

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition

Country Status (11)

Country Link
US (1) US5807573A (sv)
EP (1) EP0767656B1 (sv)
JP (1) JP3825468B2 (sv)
AT (1) ATE203399T1 (sv)
AU (1) AU2756395A (sv)
CA (1) CA2192190C (sv)
DE (1) DE69521896T2 (sv)
FI (1) FI964959A0 (sv)
NO (1) NO965380L (sv)
SE (1) SE518578C2 (sv)
WO (1) WO1995034287A1 (sv)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
SE510363C2 (sv) * 1996-09-05 1999-05-17 Gs Dev Ab Användning av en flytande kristallin fas för att bestämma fördelningen av en kemisk substans mellan en hydrofob och en hydrofil miljö
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
ES2373861T3 (es) 1997-09-18 2012-02-09 Pacira Pharmaceuticals, Inc. Composiciones anestésicas liposomiales de liberación sostenida.
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
FR2780644B1 (fr) * 1998-07-03 2001-07-20 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse et d'une phase aqueuse, stabilisee a l'aide de particules de gel cubique
SE514908C2 (sv) * 1998-07-13 2001-05-14 Gs Dev Ab Medel för benrekonstruktion
SE9802528D0 (sv) * 1998-07-13 1998-07-13 Gs Dev Ab Bone tissue restoring composition
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
US6800298B1 (en) 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) * 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
IL158819A0 (en) * 2001-05-31 2004-05-12 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
DE10127406A1 (de) * 2001-06-06 2002-12-12 Xzillion Gmbh & Co Kg Verfahren zur elektrophoretischen Trennung von Proben
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
WO2005046642A1 (en) * 2003-11-07 2005-05-26 Camurus Ab Compositions of lipids and cationic peptides
DE602005025083D1 (sv) 2004-01-23 2011-01-13 Camurus Ab
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
BRPI0511807C8 (pt) * 2004-06-04 2021-05-25 Camurus Ab pré-formulação, processo de formação de uma pré-formulação e uso da mesma
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
CA2594718C (en) * 2005-01-14 2012-01-24 Camurus Ab Gnrh analogue formulations
EP1843746B1 (en) * 2005-01-14 2011-03-16 Camurus Ab Somatostatin analogue formulations
US8920782B2 (en) * 2005-01-14 2014-12-30 Camurus Ab Topical bioadhesive formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9060935B2 (en) 2005-01-21 2015-06-23 Camurus Ab Pharmaceutical lipid compositions
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
JP5198261B2 (ja) 2005-06-06 2013-05-15 カムルス エービー Ｇｌｐ−１類似体製剤
US20070020228A1 (en) * 2005-07-22 2007-01-25 Williams Terry N Method of using a biosealant device
US20070092462A1 (en) * 2005-10-24 2007-04-26 Julio Gans Russ Cosmetic compositions
CN103071209A (zh) 2005-11-17 2013-05-01 周吉尼克斯股份有限公司 用无针注射递送粘稠制剂
EP1954384A1 (en) * 2005-11-23 2008-08-13 Nestec S.A. Oil-in-water emulsion for creating new product consistencies
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
US8333787B2 (en) 2007-12-31 2012-12-18 St. Jude Medical Puerto Rico Llc Vascular closure device having a flowable sealing material
US8568445B2 (en) 2007-08-21 2013-10-29 St. Jude Medical Puerto Rico Llc Extra-vascular sealing device and method
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
ES2528409T3 (es) * 2007-10-24 2015-02-10 Camurus Ab Formulaciones de liberación controlada
US8840640B2 (en) 2007-12-31 2014-09-23 St. Jude Medical Puerto Rico Llc Vascular closure device having an improved plug
EP2273880B1 (en) 2008-04-28 2014-12-31 Zogenix, Inc. Novel formulations for treatment of migraine
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2165706A1 (en) 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
CN105532922A (zh) * 2008-11-14 2016-05-04 阿彻丹尼尔斯米德兰德公司 有机凝胶组合物及其生产方法
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
CN102933200B (zh) 2009-12-18 2015-11-25 莱迪杜德制药公司 包含磷脂的单相凝胶组合物
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2012106634A1 (en) 2011-02-03 2012-08-09 Alexion Pharmaceuticals, Inc. Use of an anti-cd200 antibody for prolonging the survival of allografts
JP2014508166A (ja) 2011-03-17 2014-04-03 トランスダーマル バイオテクノロジ インコーポレーテッド 局所的一酸化窒素システム及びその使用方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
SI2787974T1 (sl) 2011-12-05 2017-10-30 Camurus Ab Robustno kontrolirano-sproščujoče peptidne formulacije
AU2013265210B2 (en) 2012-05-25 2016-09-15 Camurus Ab Somatostatin receptor agonist formulations
SI2877155T1 (sl) 2012-07-26 2021-04-30 Camurus Ab Opioidne formulacije
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
KR101586791B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
EP3658187A1 (en) 2017-07-27 2020-06-03 Allergan, Inc. Prostacyclin receptor agonists for reduction of body fat
JP7064612B2 (ja) * 2018-09-20 2022-05-10 富士フイルム株式会社 生体材料
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
CN117794519A (zh) * 2021-07-27 2024-03-29 法纳克斯株式会社 非层状液晶形成性组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5164191A (en) * 1991-02-12 1992-11-17 Micro Vesicular Systems, Inc. Lipid vesicles having an alkyd as a wall-forming material
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol

Also Published As

Publication number Publication date
US5807573A (en) 1998-09-15
FI964959A (sv) 1996-12-11
EP0767656A1 (en) 1997-04-16
FI964959A0 (sv) 1996-12-11
SE9402106D0 (sv) 1994-06-15
CA2192190A1 (en) 1995-12-21
DE69521896T2 (de) 2001-11-22
EP0767656B1 (en) 2001-07-25
WO1995034287A1 (en) 1995-12-21
SE518578C2 (sv) 2002-10-29
CA2192190C (en) 2004-09-21
JPH10504532A (ja) 1998-05-06
NO965380D0 (no) 1996-12-13
JP3825468B2 (ja) 2006-09-27
DE69521896D1 (de) 2001-08-30
ATE203399T1 (de) 2001-08-15
NO965380L (no) 1996-12-13
AU2756395A (en) 1996-01-05

Similar Documents

Publication Publication Date Title
SE9402106L (sv) Lipidbaserad komposition
NO843023L (no) Fremgagsmaate for fremstilling av preparater med styrt frigivelse for biologisk aktive materialer og resulterende blandinger
ZA852168B (en) Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion
DK0833611T3 (da) Sammensætning omfattende et aktivt middel opløst i en glasdannende bærer og fremgangsmåde til fremstilling heraf
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
BR8007670A (pt) Dispersoes de copolimeros em compostos polifuncionais,tendo uma serie de hidrogenios ativos,metodo para fazer as dispersoes de copolimeros e uma composicao de poliuretana preparada
SE8602931D0 (sv) A controlled-release composition
ES2170813T3 (es) Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina.
ES2042437T1 (es) Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.
PT76919A (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
GB9605915D0 (en) Liposome encapsulated amphiphilic drug compositions
AU1073688A (en) Phospholipid delivery vehicle for aqueous-insoluble active ingredients
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
DK0648115T3 (da) Præparat til reguleret frigivelse af et aktivt stof og fremgangsmåde til fremstilling af et sådant præparat
DE69100161D1 (de) Herstellungsverfahren fuer ein haarkosmetikum, zusammensetzung und kosmetisches behandlungsverfahren.
GB9819160D0 (en) Pellistor
AU1314095A (en) Oil-in-water emulsions
ZA987480B (en) Process for preparing contrast agents.
HUT36985A (en) Herbicides containing diphenyl-ethers as active ingredient and method for producing active ingredients
AU4372899A (en) Difluoroalkencarboxanilides and pesticidal compositions
DE3372765D1 (en) Carbamic-acid esters, process and starting material for their preparation, parasiticides containing these esters as active products, as well as the use of such esters and agents in combating parasites
CA2110491A1 (en) Gas filled liposomes and their use as ultrasonic contrast agents

Legal Events

Date Code Title Description
NUG Patent has lapsed